Diagnostics

Blood biomarkers for the diagnosis of Alzheimer’s disease

Predictive factors of progression from mild cognitive impairment to dementia

Diagnosing mild cognitive impairment

Ethical considerations when investigating the causes of mild cognitive impairment

A practical approach to cognitive impairment management

Important developments in dementia: biomarkers & clinical trials

Therapeutic implications of caspase-cleaved tau in AD

Novel probe for selective imaging of tau tangles in human retina

Function of the lymphatic system: fluid volume control, drainage systems & immunosurveillance

Vascular scores can be utilized to predict cortical microinfarcts

Advances in Alzheimer’s disease biomarkers & therapies

Greatest needs in dementia research: early diagnosis

Optimizing image segmentation tools for use in a clinical setting

Differences between Alzheimer’s disease biomarkers: p-Tau181, p-Tau231 & p-Tau217

The use of Alzheimer’s disease plasma biomarkers in the clinic: further research needed

Challenges in the clinical implementation of Alzheimer’s disease biomarkers